TenCate awarded important US defense contract of US Dollar

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TenCate awarded important US defense contract of US Dollar 30 million

ALMELO, Netherlands, April 16, 2014 (GLOBE NEWSWIRE) -- TenCate Advanced Armor in Newark (Ohio), USA, has been selected by General Dynamics Ordnance and Tactical Systems, the prime contractor for the U.S. Army Special Operations Command (SOCOM) Ground Mobility Vehicle, to provide the GMV 1.1 armor solution. This order has a value of about US Dollar 30 million. Revenues will be generated in the next three to four years. Initial production will start during the second half of 2014.     

The Pentagon awarded General Dynamics Ordnance and Tactical Systems a US Dollar 562 million contract for the Ground Mobility Vehicle (GMV 1.1). SOCOM plans to purchase up to 1,300 GMVs over the next 6 years to replace SOCOM's current fleet of specialized High Mobility Multipurpose Wheeled Vehicles (HMMWVs).
  
Complete vehicle survivability solution

TenCate Advanced Armor offers complete vehicle armor and occupant survivability solutions for tactical and combat vehicles. Utilizing a wide range of armor materials and technologies, survivability products of TenCate include lightweight passive armor as well as advanced active underbody IED protection. "We are extremely excited to be a part of the GD-OTS team. The GMV platform is a perfect platform for our lightweight armor solutions", says Mark Edwards, President of TenCate Advanced Armor USA. "The GMV program is certainly an important part of the future enabling technologies for the United States Army Special Forces and we are proud to be able to participate on such an important program." The TenCate GMV armor solution consists of the primary vehicle armoring solution including transparent armor. TenCate will design and manufacture the armor and provide it to GD-OTS as a complete kit ready for installation.

Order book of projects

This order of General Dynamics Ordnance and Tactical Systems forms part of a total order book of projects in excess of US Dollar 100 million, which TenCate Advanced Armor is expecting to receive during 2014. Revenues out of this order book will be generated during the next four years.

Royal Ten Cate
Almelo, the Netherlands, Wednesday 16 April 2014
________________________________________________________________________________

For further information:

Digital pictures are available on your request via: media@tencate.com

Disclaimer: reference herein to any specific commercial company, product, process or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement recommendation or favoring by the United States Government or the Department of the Army (DoA). The opinions of the authors expressed herein do not necessarily state or reflect those of the United States government or the DoA,and shall not be used for advertising or product endorsement purposes.

TenCate corporate
Pieter Zwinkels, Manager Investor Relations
Telephone      : +31 546 544 911
Mobile           : +31 6 1088 6338
Email            : p.zwinkels@tencate.com
Internet         : www.tencate.com

TenCate Advanced Armor USA
Mark Edwards, President
Telephone      : +1 740 345 5574
Email            : advancedarmor@tcaa-usa.com
Internet         : www.tencateadvancedarmor.com

TenCate Advanced Armor is a leading global supplier of a wide range of armor composite materials for ballistic protection. TenCate Advanced Armor develops and produces a portfolio of composite and ceramic materials and designs active armor solutions for the protection of police, army, air force, navy and civilian service personnel, vehicles and vessels. TenCate Advanced Armor has facilities in North America, Europe and Asia.

Royal Ten Cate (TenCate) is a multinational company that combines textile technology with chemical processes and material technology in the development and production of functional materials with distinctive characteristics. TenCate products are sold throughout the world. Systems and materials from TenCate come under four areas of application: safety and protection; space and aerospace; infrastructure and the environment; sport and recreation. TenCate occupies leading positions in protective fabrics, composites for space and aerospace, antiballistics, geosynthetics and synthetic turf. TenCate is listed on NYSE Euronext (AMX).

Press release as PDF http://hugin.info/130798/R/1777641/606866.pdf

HUG#1777641

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading